WCM Investment Management’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-663,733
Closed -$8.25M 218
2023
Q1
$8.25M Buy
663,733
+4,749
+0.7% +$87.4K 0.03% 141
2022
Q4
$12.7M Sell
658,984
-14,023
-2% -$296K 0.04% 108
2022
Q3
$12.9M Buy
673,007
+20,501
+3% +$421K 0.05% 97
2022
Q2
$12.1M Buy
652,506
+129,102
+25% +$2.1M 0.04% 105
2022
Q1
$8.39M Buy
523,404
+64,306
+14% +$1.16M 0.02% 133
2021
Q4
$11.2M Buy
459,098
+204,868
+81% +$4.81M 0.03% 125
2021
Q3
$5.92M Sell
254,230
-225,389
-47% -$5.45M 0.01% 145
2021
Q2
$13.1M Buy
479,619
+100,279
+26% +$2.86M 0.03% 91
2021
Q1
$13.9M Buy
+379,340
New +$13.4M 0.04% 77

Other funds holding AHCO

WCM Investment Management's AHCO Position: Q2 2023 in Review

WCM Investment Management sold out of AdaptHealth (AHCO) in Q2 2023, closing a stake of 663,733 shares — an estimated $8.25M sold.

WCM Investment Management first reported a position in AHCO in Q1 2021 and held it in 9 quarters. The position peaked at $13.9M in Q1 2021. 182 funds tracked by Wall St. Rank hold AHCO as of Q2 2023.

  • WCM Investment Management reported no remaining AdaptHealth position as of Q2 2023 after selling out during the quarter.
  • WCM Investment Management sold 663,733 AdaptHealth shares in Q2 2023, an estimated $8.25M.
  • WCM Investment Management first reported a position in AdaptHealth in Q1 2021 and held it in 9 quarters.
  • WCM Investment Management's AdaptHealth position peaked at $13.9M in Q1 2021.
  • 182 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2023.

Based on WCM Investment Management's 13F filing for Q2 2023, filed 14 Jul 2023.